Columbus McKinnon (CMCO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CMCO Columbus McKinnon

Watchlist

18.490
-0.410-2.17%

Close Feb 24 16:00 ET

18.500
+0.010+0.05%

Pre 08:00 ET

529.05MMarket Cap57.78P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Offer Insights on Industrial Goods Companies: ESAB Corporation (ESAB), XPO (XPO) and Columbus Mckinnon (CMCO)
TipRanksFeb 24 07:12 ET · Ratings
J.P. Morgan Reaffirms Their Buy Rating on Columbus Mckinnon (CMCO)
TipRanksFeb 24 07:11 ET · Ratings
Columbus McKinnon's Q4 Performance: A Deep Dive Into the Numbers and Market Implications
Globe PR WireFeb 24 06:01 ET
Express News | Columbus McKinnon Corp : JP Morgan Cuts Target Price to $31 From $48
ReutersFeb 21 09:27 ET
Executives Show Confidence With Major Columbus McKinnon Stock Purchases
TipRanksFeb 14 21:02 ET
Catalyst Watch: Apple Product Event, Walmart Earnings, Sandisk Debut, and Visa's Investor Day
Seeking AlphaFeb 14 15:00 ET

Comments

QING WEI 95

Feb 11 10:12

$Columbus McKinnon (CMCO.US)$ what happens drop so much

Moomoo AI

Feb 5, 2024 08:16

Insider's sale of shares at a lower price may suggest belief in the stock's full valuation. However, this is a weak sign and doesn't definitively indicate their view on the stock's value. The lack of insider buying recently and history of sales make us cautious about the stock.

Senior Vice President of Global Product Development & Marketing Mario Ramos Lara Sold A Bunch Of Shares In Columbus McKinnon

Moomoo AI

Jan 4, 2024 11:55

Columbus McKinnon's high P/E compared to the market appears justified due to expected earnings growth and potential EPS increase. This is anticipated to strongly support the share price, barring changes in circumstances.

Getting In Cheap On Columbus McKinnon Corporation (NASDAQ:CMCO) Might Be Difficult

Analysts Notebook

May 27, 2022 08:58

Columns Analysts' screen via BofA, JPMorgan, Morgan Stanley, Mizuho and more

BOFA
• $Oscar Health (OSCR.US)$ BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...

Analysts Notebook

May 26, 2022 05:30

Columns Top upgrades and downgrades on 5/26

Upgrades
• $AmerisourceBergen (ABC.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare (ALHC.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $Cigna Group (CI.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $Canadian National Railway (CNI.US)$ : Evercore ISI Upgrades to Outperform from In Line
• $Youdao (DAO.US)$ : Citic Securities Upgrades to Buy from Neut...

Trending Stocks

Symbol Mini Chart % Chg

Unlock the Full List